Peel vs laser: which skin fix wins?

NCT ID NCT07036302

Ongoing Symptom relief Sponsor: Jose Roberto Cortelli Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two common cosmetic treatments—chemical peels using trichloroacetic acid (TCA) and fractional lasers—for improving melasma, acne scars, and wrinkles. About 120 adults will receive three sessions of one treatment, and researchers will measure skin changes, satisfaction, and quality of life. The goal is to find which approach works best and is most comfortable for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: trichloroacetic acid (TCA) chemical peel and fractional laser (Erbium-YAG and Neodymium-YAG)
What this could lead to: If successful, this could help doctors choose the most effective and comfortable skin-resurfacing treatment for melasma, acne scars, and wrinkles.
What could go wrong: This is a small, early-stage comparison study. Results may not apply to all skin types or guarantee long-term improvement. Risks include pain, scarring, and uneven skin tone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE SCARS - MIXED ATROPHIC AND HYPERTROPHIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypertrophy Melanosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE SCARS - MIXED ATROPHIC AND HYPERTROPHIC MELASMA REJUVENATION RESURFACING

Contacts and locations

Locations

Cavalca & Cortelli Research Center

Taubaté, São Paulo, 12010-700, Brazil
University of Taubate Dental School

Taubaté, São Paulo, 12020-330, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.